摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

m7GpppG | 959909-41-2

中文名称
——
中文别名
——
英文名称
m7GpppG
英文别名
(N(7)-methyl 5'-triphospho-guanosine)-guanosine;[[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate
m<sup>7</sup>GpppG化学式
CAS
959909-41-2
化学式
C21H27N10O18P3
mdl
——
分子量
800.423
InChiKey
FHHZHGZBHYYWTG-INFSMZHSSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.9
  • 重原子数:
    52
  • 可旋转键数:
    12
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    439
  • 氢给体数:
    8
  • 氢受体数:
    25

反应信息

  • 作为反应物:
    描述:
    m7GpppG 在 10-(imidazol-4-yl-CH2)tetraazacyclotetradecaphane derivative 作用下, 生成 、 7-methylguanosine 5'-diphosphate 、 7-methylguanosine 5'-monophosphateGDP
    参考文献:
    名称:
    Regio-selective synthesis of polyazacyclophanes incorporating a pendant group as potential cleaving agents of mRNA 5′-cap structure
    摘要:
    A terpyridine or an imidazole unit has been tethered to an N-protected polyazacyclophane to give the appropriate N-monofunctionalized polyazacyclophane. After mild deprotection, four polyazacyclophanes incorporating a pendant group were obtained in satisfactory yields. Their preliminary cleavage ability of mRNA 5'-cap model was studied at pH 7.2. Published by Elsevier Ltd.
    DOI:
    10.1016/j.tet.2007.08.102
  • 作为产物:
    描述:
    鸟苷酸 在 N-ethylmorpholine buffer 、 triphenylphosphine-dipyridyl disulfide 、 三乙基碳酸氢铵缓冲液 、 manganese(ll) chloride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 96.0h, 生成 m7GpppG
    参考文献:
    名称:
    Facile synthesis of cap portion of messenger RNA by Mn(II) ion-catalyzed pyrophosphate formation in aqueous solution
    摘要:
    Cap portion of messenger RNA was prepared by Mn2+ ion-catalyzed pyrophosphate bond formation from 7-methylguanosine-5'-phosphorimidazolide and nucleoside diphosphate in neutral aqueous solution.
    DOI:
    10.1016/0040-4039(91)80440-h
点击查看最新优质反应信息

文献信息

  • Identification of a quality-control mechanism for mRNA 5′-end capping
    作者:Xinfu Jiao、Song Xiang、ChanSeok Oh、Charles E. Martin、Liang Tong、Megerditch Kiledjian
    DOI:10.1038/nature09338
    日期:2010.9.30
    Following their transcription, eukaryotic messenger RNAs have a 7-methylguanosine cap added to their 5′ ends to protect the mRNA from degradation. Xinfu Jiao et al. show that caps lacking a methyl group are recognized by Rai1, which clips off the incomplete cap. These data suggest that Rai1 is part of a quality-control mechanism that monitors and promotes the digestion of aberrant mRNAs that may arise during stress conditions. Following their synthesis, eukaryotic messenger RNAs have a 7-methylguanosine cap added to their 5′ ends to protect the mRNAs from degradation. Here it is shown that, in vitro and in yeast, caps lacking a methyl group are recognized by the Rai1 protein, which clips off the incomplete cap. The data provide evidence that Rai1 is part of a quality-control mechanism that monitors, and promotes the digestion of, aberrant mRNAs that might arise during stress conditions. The 7-methylguanosine cap structure at the 5′ end of eukaryotic messenger RNAs is a critical determinant of their stability and translational efficiency1,2,3. It is generally believed that 5′-end capping is a constitutive process that occurs during mRNA maturation and lacks the need for a quality-control mechanism to ensure its fidelity. We recently reported that the yeast Rai1 protein has pyrophosphohydrolase activity towards mRNAs lacking a 5′-end cap4. Here we show that, in vitro as well as in yeast cells, Rai1 possesses a novel decapping endonuclease activity that can also remove the entire cap structure dinucleotide from an mRNA. This activity is targeted preferentially towards mRNAs with unmethylated caps in contrast to the canonical decapping enzyme, Dcp2, which targets mRNAs with a methylated cap. Capped but unmethylated mRNAs generated in yeast cells with a defect in the methyltransferase gene are more stable in a rai1-gene-disrupted background. Moreover, rai1Δ yeast cells with wild-type capping enzymes show significant accumulation of mRNAs with 5′-end capping defects under nutritional stress conditions of glucose starvation or amino acid starvation. These findings provide evidence that 5′-end capping is not a constitutive process that necessarily always proceeds to completion and demonstrates that Rai1 has an essential role in clearing mRNAs with aberrant 5′-end caps. We propose that Rai1 is involved in an as yet uncharacterized quality control process that ensures mRNA 5′-end integrity by an aberrant-cap-mediated mRNA decay mechanism.
  • An effective method for the synthesis of the cap structure of eukaryotic messenger ribonucleic acids
    作者:Takashi Kamimura、Yumi Osaki、Mitsuo Sekine、Tsujiaki Hata
    DOI:10.1016/s0040-4039(01)81262-4
    日期:1984.1
  • Synthesis and Properties of P1, P2-, P1, P3- and P1, P4-Dinucleoside Di-, Tri- and Tetraphosphate mRNA 5'-Cap Analogues
    作者:J. Steogon、pinski、M. Bretner、M. Jankowska、K. Felczak、R. Stolarski、Z. Wieczorek、A-L. Caipostalcode、R. E. Rhoads、A. Temeriusz、D. Haber、E. Darzynkiewicz
    DOI:10.1080/15257779508012457
    日期:1995.5.1
  • A Mammalian Pre-mRNA 5′ End Capping Quality Control Mechanism and an Unexpected Link of Capping to Pre-mRNA Processing
    作者:Xinfu Jiao、Jeong Ho Chang、Turgay Kilic、Liang Tong、Megerditch Kiledjian
    DOI:10.1016/j.molcel.2013.02.017
    日期:2013.4
    Recently, we reported that two homologous yeast proteins, Rail and Dxo1, function in a quality control mechanism to clear cells of incompletely 5' end-capped messenger RNAs (mRNAs). Here, we report that their mammalian homolog, Dom3Z (referred to as DXO), possesses pyrophosphohydrolase, decapping, and 5'-to-3' exoribonuclease activities. Surprisingly, we found that DXO preferentially degrades defectively capped pre-mRNAs in cells. Additional studies show that incompletely capped pre-mRNAs are inefficiently spliced at all introns, a fact that contrasts with current understanding, and are also poorly cleaved for polyadenylation. Crystal structures of DXO in complex with substrate mimic and products at a resolution of up to 1.5 angstrom provide elegant insights into the catalytic mechanism and molecular basis for their three apparently distinct activities. Our data reveal a pre-mRNA 5' end capping quality control mechanism in mammalian cells, indicating DXO as the central player for this mechanism, and demonstrate an unexpected intimate link between proper 5' end capping and subsequent pre-mRNA processing.
  • Regio-selective synthesis of polyazacyclophanes incorporating a pendant group as potential cleaving agents of mRNA 5′-cap structure
    作者:Zhibo Zhang、Satu Mikkola、Harri Lonnberg
    DOI:10.1016/j.tet.2007.08.102
    日期:2007.11
    A terpyridine or an imidazole unit has been tethered to an N-protected polyazacyclophane to give the appropriate N-monofunctionalized polyazacyclophane. After mild deprotection, four polyazacyclophanes incorporating a pendant group were obtained in satisfactory yields. Their preliminary cleavage ability of mRNA 5'-cap model was studied at pH 7.2. Published by Elsevier Ltd.
查看更多

同类化合物

鸟苷(5')四磷酰(5')鸟苷 还原辅酶Ⅱ四钠盐 还原型辅酶Ⅰ 还原型辅酶II(NADPH)四钠盐 苯(甲)醛,4-乙酰基-,1-肟 腺苷(5')四磷酸酯尿苷 硫代辅酶腺嘌呤二核苷磷酸钠 硫代烟酰胺-DPN 甲基N~5~-(二氨基甲亚基)-N~2~-[(3S,4S)-3-羟基-4-({N-[(4S)-3-羟基-6-甲基-4-{[(2S)-3-甲基-1-{[N-(3-甲基丁酰)-L-缬氨酰]氨基}-1-羰基丁烷-2-基]氨基}庚酰]-L-丙氨酰}氨基)-6-甲基庚酰]-L-鸟氨酸酸酯 烟酸腺嘌呤二核苷酸磷酸酯 烟酰胺腺嘌呤双核苷酸磷酸盐 烟酰胺腺嘌呤二核苷酸 烟酰胺1,N(6)-乙烯桥腺嘌呤二核苷酸 尿苷酰基-(3'-5')-腺苷酰-(3'-5')尿苷 尼克酰胺2-叠氮氨基嘌呤二核苷酸 地纽福索四钠 地夸磷索 八磷酸腺苷 二腺苷三磷酸酯铵盐 二喹唑醇杂质1 β-烟酰胺腺嘌呤二核苷酸 β,β'-单氯亚甲基二腺苷5',5''-P(1),P(4)-四磷酸酯 beta-烟酰胺腺嘌呤二核苷二钠 [[[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰][(2R,3S,4R,5R)-5-(3,4-二甲基吡啶-1-鎓-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸酯 [[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰][(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基-8-叠氮基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[(2R,3S,4R,5R)-5-(3-氨基甲酰-4H-吡啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]磷酸氢酯 P(1)-(腺苷-5')-P(5)-(胸苷-5')-五磷酸酯 BETA-烟酰胺腺嘌呤双核苷酸 Alpha-二磷酸啶核甙酸 3-苯甲酰基吡啶-腺嘌呤二核苷酸 3-氨基吡啶腺嘌呤二核苷酸 3-吡啶乙醛腺嘌呤二核苷酸 3-乙酰吡啶腺嘌呤二核苷酸 3'-脱氧烟酰胺腺嘌呤二核苷酸 2-氟-6-甲氧基苯甲腈 2'-脱氧腺苷酰-(3'-5')-胸苷 1-[5-[[[[5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲氧基-羟基-磷酰]氧基-羟基-磷酰]氧基甲基]-3,4-二羟基-四氢呋喃-2-基]吡啶-5-羧酸酯 1,6-二氢烟酰胺腺嘌呤二核苷酸 1,2-二氢烟酰胺腺嘌呤二核苷酸 (2S,3S,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基甲基]-2-(3-氨基甲酰吡啶-1-鎓-1-基)-4-羟基四氢呋喃-3-醇 (2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基甲基]-2-(3-氨基甲酰-5-甲基吡啶-1-鎓-1-基)-4-羟基四氢呋喃-3-醇 (14β)-8-甲基罗汉松-12-烯-13,14-二甲醛 P1,P4-bis(uridin-5'-yl) tetraphosphate 2',2'',3',3''-O-tetrabutyryl 1,N6-etheno NAD+ β-nicotinamide adenine dinucleotide reduced 3'-azido-3'-deoxy-5'-thymidinyl 5'-uridinyl phosphate 5'-adenosyl 3'-azido-3'-deoxy-5'-thymidinyl phosphate